Approval · Notice of Compliance 1101 · 2000
RYTHMODAN: Notice of Compliance 1101
Issued July 21, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1101
- Date
- July 21, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antiarrhythmic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RYTHMODAN | 02224801 | Dormant |
| RYTHMODAN | 02224828 | Cancelled Post Market |
| RYTHMODAN-LA | 02224836 | Cancelled Post Market |
Medicinal ingredients
- DISOPYRAMIDE 100 MG per CAP
- DISOPYRAMIDE 150 MG per CAP
- DISOPYRAMIDE PHOSPHATE 250 MG per TAB